Atlas Trials

Effect of Bimekizumab in Patients With Psoriasis Vulgaris and Active Psoriatic Arthritis

Clinical trial NCT05499416 · WITHDRAWN

Trial details

NCT number
NCT05499416
Sponsor
Innovaderm Research Inc.
Status
WITHDRAWN
Phase
Phase 4
Study type
INTERVENTIONAL
Psoriasis VulgarisActive Psoriatic Arthritis
Start date
2023-01-01
Primary completion
2023-09-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.